ASX - By Stock
|
HZN |
Re:
How Big will Distribution be
|
|
ces
|
44 |
14K |
2 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
44
|
14K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
0 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
1 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
3 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
3
|
|
ASX - By Stock
|
MAY |
Re:
Ann: Zapato-1ST Drilling Update
|
|
ces
|
421 |
163K |
1 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
421
|
163K
|
1
|
|
ASX - By Stock
|
MAY |
Re:
Ann: Zapato-1ST Drilling Update
|
|
ces
|
421 |
163K |
0 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
421
|
163K
|
0
|
|
ASX - By Stock
|
MAY |
Re:
Ann: Zapato-1ST Drilling Update
|
|
ces
|
421 |
163K |
26 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
421
|
163K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Voluntary Suspension
|
|
ces
|
332 |
118K |
13 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
332
|
118K
|
13
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Commencement of WZ6-12 Workover and Drilling Programme
|
|
ces
|
16 |
4.8K |
4 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
16
|
4.8K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
11 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
11
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Quarterly Activities Report
|
|
ces
|
59 |
16K |
0 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
59
|
16K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
News Flow from 21/7/22
|
|
ces
|
2 |
1.0K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
2
|
1.0K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
5 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
7 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
9 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
17K
|
6.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
5 |
03/07/22 |
03/07/22 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
3 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Information from HZN website
|
|
ces
|
3 |
1.4K |
1 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
3
|
1.4K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
ces
|
4.7K |
1.1M |
5 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
ces
|
1.5K |
505K |
0 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
1.5K
|
505K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
ces
|
1.5K |
505K |
1 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
1.5K
|
505K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
ces
|
1.5K |
505K |
0 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
1.5K
|
505K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
EV 175. Quarterly cash flow of 38- 39 m
|
|
ces
|
4 |
1.9K |
1 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
4
|
1.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ceasing to be a substantial holder
|
|
ces
|
19 |
6.6K |
3 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
19
|
6.6K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Capital Management - will we get an update in the Mar 22 Quarterly
|
|
ces
|
17 |
4.8K |
1 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
17
|
4.8K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Capital Management - will we get an update in the Mar 22 Quarterly
|
|
ces
|
17 |
4.8K |
0 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
17
|
4.8K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Capital Management - will we get an update in the Mar 22 Quarterly
|
|
ces
|
17 |
4.8K |
0 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
17
|
4.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
7 |
17/04/22 |
17/04/22 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
HZN |
Re:
Wei 12-8 EAST Project - My Take
|
|
ces
|
11 |
4.8K |
2 |
15/04/22 |
15/04/22 |
ASX - By Stock
|
11
|
4.8K
|
2
|
|
ASX - By Stock
|
HZN |
Re:
Wei 12-8 EAST Project - My Take
|
|
ces
|
11 |
4.8K |
0 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
11
|
4.8K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Wei 12-8 EAST Project - My Take
|
|
ces
|
11 |
4.8K |
0 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
11
|
4.8K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Jury Still Out on CSL
|
|
ces
|
70 |
33K |
0 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
70
|
33K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
3 |
09/04/22 |
09/04/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
10 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
17K
|
6.7M
|
10
|
|
ASX - By Stock
|
HZN |
Re:
Ann: HZN commencement of WZ12-8E drilling programme
|
|
ces
|
16 |
5.8K |
0 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
16
|
5.8K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Ann: HZN commencement of WZ12-8E drilling programme
|
|
ces
|
16 |
5.8K |
2 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
16
|
5.8K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
ces
|
1.0K |
330K |
17 |
26/03/22 |
26/03/22 |
ASX - By Stock
|
1.0K
|
330K
|
17
|
|
ASX - By Stock
|
HZN |
Re:
Ann: HZN commencement of WZ12-8E drilling programme
|
|
ces
|
16 |
5.8K |
4 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
16
|
5.8K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
7 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Is Rome burning
|
|
ces
|
90 |
25K |
20 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
90
|
25K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
ces
|
1.0K |
330K |
3 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
1.0K
|
330K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
ces
|
1.0K |
330K |
5 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
1.0K
|
330K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
RWE for 2nd MSB COVID-19 ARDS P3 Trial
|
|
ces
|
905 |
289K |
14 |
05/02/22 |
05/02/22 |
ASX - By Stock
|
905
|
289K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Dr Eric Rose
|
|
ces
|
19 |
5.7K |
14 |
05/02/22 |
05/02/22 |
ASX - By Stock
|
19
|
5.7K
|
14
|
|
ASX - By Stock
|
HZN |
Re:
How Much Oil Will HZN Produce from Beibu Gulf and Maari/Maania?
|
|
ces
|
20 |
6.0K |
1 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
20
|
6.0K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
How Much Oil Will HZN Produce from Beibu Gulf and Maari/Maania?
|
|
ces
|
20 |
6.0K |
0 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
20
|
6.0K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
How Much Oil Will HZN Produce from Beibu Gulf and Maari/Maania?
|
|
ces
|
20 |
6.0K |
3 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
20
|
6.0K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
CHF - MSB's Dark Horse with Multi-billion dollar potential
|
|
ces
|
516 |
156K |
7 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
516
|
156K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
CHF - MSB's Dark Horse with Multi-billion dollar potential
|
|
ces
|
516 |
156K |
8 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
516
|
156K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
ces
|
1.0K |
330K |
1 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
1.0K
|
330K
|
1
|
|